Joseph M. Beechem, PhD, has served as the chief scientific officer and senior vice president of Research and Development at NanoString Technologies since April 2012.
Before joining NanoString, Joseph Beechem held various positions at Life Technologies, a publicly traded biotechnology tools company. He most recently served as vice president, head of Advanced Sequencing, and head of Global Sequencing Chemistry, Biochemistry, and Biophysics. During his career at Life Technologies, he led the design and development of multiple genetic analysis technologies, the latest advanced SOLiD sequencing technology, and the single-molecule nano-DNA sequencing technology.
Prior to his industry experience, Joseph Beechem led a National Institute of Health (NIH)-funded research laboratory for 11 years as a tenured associate professor at Vanderbilt University. He also authored more than 200 peer-reviewed papers in diverse fields such as cancer immunology, infectious disease, imaging, biomathematics, physics, chemistry, spectroscopy, and diagnostics. In addition, Joseph Beechem is named on nearly 50 US patents or patent applications and has served on several editorial and scientific advisory boards.
Joseph Beechem received a BS in Chemistry and Biology from Northern Kentucky University and a PhD in Biophysics from Johns Hopkins University.